Harbour BioMed

Year founded

-

Country of origin

China

HQ country

China

Total deal value

Login to see more

Average deal value

Login to see more

Company industry

  • Medical & Biotech

M&A expertise

  • -

Industry expertise

  • Medical & Biotech
Company background

Harbour BioMed was established in 2016 with an initial financing of USD 50m from Advantech Capital, Legend Capital and the Harbour BioMed founding team. The company is headquartered with R&D operations in Shanghai, business operations in Cambridge, MA, and antibody platform innovation operations in Rotterdam, The Netherlands.

Almost there!

You are only one step away from access to the most comprehensive deal database of the Netherlands and Belgium.

Start optimising your deal analysis Start optimising your deal analysis

Already have an account? Please login